Daniel J Lodge

Summary

Affiliation: University of Texas Health Science Center
Country: USA

Publications

  1. pmc Developmental pathology, dopamine, stress and schizophrenia
    Daniel J Lodge
    Department of Pharmacology and Center for Biomedical Neuroscience, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, MC 7764, San Antonio, TX 78229, USA
    Int J Dev Neurosci 29:207-13. 2011
  2. pmc The medial prefrontal and orbitofrontal cortices differentially regulate dopamine system function
    Daniel J Lodge
    Department of Pharmacology and Center for Biomedical Neuroscience, University of Texas Health Science Center, San Antonio, TX, USA
    Neuropsychopharmacology 36:1227-36. 2011
  3. pmc Aberrant dopamine D2-like receptor function in a rodent model of schizophrenia
    Stephanie M Perez
    Department of Pharmacology, Center for Biomedical Neuroscience, University of Texas Health Science Center, 7703 Floyd Curl Drive, MC 7764, San Antonio, TX 78229, USA
    J Pharmacol Exp Ther 343:288-95. 2012
  4. pmc Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia
    Daniel J Lodge
    Department of Pharmacology and Center for Biomedical Neuroscience, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
    Trends Pharmacol Sci 32:507-13. 2011
  5. pmc The MAM rodent model of schizophrenia
    Daniel J Lodge
    Department of Pharmacology and Center for Biomedical Neuroscience, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
    Curr Protoc Neurosci . 2013
  6. pmc Hippocampal deep brain stimulation reverses physiological and behavioural deficits in a rodent model of schizophrenia
    Stephanie M Perez
    Department of Pharmacology and Center for Biomedical Neuroscience, University of Texas Health Science Center, San Antonio, TX 78229, USA
    Int J Neuropsychopharmacol 16:1331-9. 2013
  7. pmc Distinct prefrontal cortical regions negatively regulate evoked activity in nucleus accumbens subregions
    Amber Asher
    Department of Pharmacology and Center for Biomedical Neuroscience, University of Texas Health Science Center, San Antonio, TX, USA
    Int J Neuropsychopharmacol 15:1287-94. 2012

Research Grants

  1. Regulation of ventral hippocampal system function
    Daniel J Lodge; Fiscal Year: 2010

Collaborators

  • Stephanie M Perez
  • Amber Asher
  • Amiksha Shah

Detail Information

Publications7

  1. pmc Developmental pathology, dopamine, stress and schizophrenia
    Daniel J Lodge
    Department of Pharmacology and Center for Biomedical Neuroscience, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, MC 7764, San Antonio, TX 78229, USA
    Int J Dev Neurosci 29:207-13. 2011
    ..Such information is critical for our understanding into the pathology of psychiatric disease with the ultimate aim being the development of more effective therapeutics...
  2. pmc The medial prefrontal and orbitofrontal cortices differentially regulate dopamine system function
    Daniel J Lodge
    Department of Pharmacology and Center for Biomedical Neuroscience, University of Texas Health Science Center, San Antonio, TX, USA
    Neuropsychopharmacology 36:1227-36. 2011
    ..Taken together, these data demonstrate that the mPFC and OFC differentially regulate dopamine neuron activity, and that the pattern of cortical activation is critical for determining dopamine system output...
  3. pmc Aberrant dopamine D2-like receptor function in a rodent model of schizophrenia
    Stephanie M Perez
    Department of Pharmacology, Center for Biomedical Neuroscience, University of Texas Health Science Center, 7703 Floyd Curl Drive, MC 7764, San Antonio, TX 78229, USA
    J Pharmacol Exp Ther 343:288-95. 2012
    ....
  4. pmc Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia
    Daniel J Lodge
    Department of Pharmacology and Center for Biomedical Neuroscience, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
    Trends Pharmacol Sci 32:507-13. 2011
    ..Indeed, initial studies demonstrate that allosteric modulation of the α5GABA(A) receptor can decrease aberrant dopamine signaling and associated behaviors in a verified rodent model of psychosis...
  5. pmc The MAM rodent model of schizophrenia
    Daniel J Lodge
    Department of Pharmacology and Center for Biomedical Neuroscience, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
    Curr Protoc Neurosci . 2013
    ..This unit describes the procedures required to safely induce the MAM phenotype in rats. In addition, we describe a simple behavioral procedure, amphetamine-induced hyperlocomotion, which can be utilized to verify the MAM phenotype...
  6. pmc Hippocampal deep brain stimulation reverses physiological and behavioural deficits in a rodent model of schizophrenia
    Stephanie M Perez
    Department of Pharmacology and Center for Biomedical Neuroscience, University of Texas Health Science Center, San Antonio, TX 78229, USA
    Int J Neuropsychopharmacol 16:1331-9. 2013
    ..Therefore, we have provided initial preclinical evidence demonstrating the feasibility of hippocampal DBS as a potential novel approach for the treatment of schizophrenia...
  7. pmc Distinct prefrontal cortical regions negatively regulate evoked activity in nucleus accumbens subregions
    Amber Asher
    Department of Pharmacology and Center for Biomedical Neuroscience, University of Texas Health Science Center, San Antonio, TX, USA
    Int J Neuropsychopharmacol 15:1287-94. 2012
    ....

Research Grants1

  1. Regulation of ventral hippocampal system function
    Daniel J Lodge; Fiscal Year: 2010
    ..abstract_text> ..